Oroville Hospital has been awarded a three-year term of accreditation for stereotactic breast biopsy as the result of a recent review by the American College of Radiology (ACR). This certification follows a previous accreditation for mammography by the ACR.
An accreditation by the ACR represents the highest level of image quality and patient safety for a stereotactic breast biopsy. The award is only given to facilities that meet ACR Practice Parameters and Technical Standards after a peer-reviewed evaluation by board-certified physicians and medical physicists who are experts in radiology. Facilities are assessed on image quality, personnel qualifications, adequacy of facility equipment, quality control procedures and quality assurance programs.
“We are proud to receive an additional accreditation and recognition for our radiology department,” said Robert J. Wentz, President and Chief Executive Officer of Oroville Hospital. “Providing access to state-of-the-art imaging technology, advanced diagnostic techniques and quality care is a key component of the services we provide here.”
A stereotactic breast biopsy procedure is typically used in instances of breast tissue calcification or when abnormalities are difficult to view with a standard ultrasound. A radiologist uses a mammography machine to guide instruments to the site of abnormal growth. Tissue cells are removed either surgically or using a hollow needle from areas suspected of being cancerous. They are then examined under a microscope to determine a diagnosis.
While a diagnosis is the first step in treating breast cancer, Oroville Hospital’s breast cancer care program offers a collaborative team of medical professionals who work closely with each patient to decide the best treatment plan. In addition, the hospital’s extensive network of medical and surgical specialists ensures patients are able to easily obtain quality and personalized cancer treatment at home.